Skip to main content
. 2020 Feb 27;20(2):219–230. doi: 10.1007/s10238-020-00618-3

Fig. 5.

Fig. 5

Gal-9 expression by peripheral blood mononuclear cells in HCV patients on DAA treatment. The expression of PD-L1 by CD3+, CD4+, CD8+ T cells, NK, NKdim, NKbright and NKT-like cells, monocytes and Treg cells in HCV patients on DAA treatment. The solid bars represent medians of 14 determinations, and the boxes indicate the interquartile ranges and the lines show the most extreme observations. Differences were considered statistically significant for p values ≤ 0.05